Abstract

COVID-19 is hopefully approaching its end in many countries as herd immunity develops and weaker strains of SARS-CoV-2 dominate. However, a new concern occurs over the long-term effects of COVID-19, collectively called "Long COVID", as some symptoms of the nervous system last even after patients recover from COVID-19. This review focuses on studies of anosmia, , impairment of smell, which is the most common sensory defect during the disease course and is caused by olfactory dysfunctions. It remains mysterious how the olfactory functions are affected since the virus can't invade olfactory receptor neurons. We describe several leading hypotheses about the mystery in hope to provide insights into the pathophysiology and treatment strategies for anosmia.

MeSH

Smell, Anosmia, Post-Acute Covid-19 Syndrome

Cited by

• The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID. Signal Transduct Target Ther, 2023
• Cognitive Sequelae of COVID-19: Mechanistic Insights and Therapeutic Approaches. CNS Neurosci Ther, 2025
• What we learned from lifting COVID-19 restrictions in Macao in December 2022. Int J Biol Sci, 2023
• Choroid plexus defects in Down syndrome brain organoids enhance neurotropism of SARS-CoV-2. Sci Adv, 2024
• Mechanism and treatment of olfactory dysfunction caused by coronavirus disease 2019. J Transl Med, 2023
• Deprivation-Induced Plasticity in the Early Central Circuits of the Rodent Visual, Auditory, and Olfactory Systems. eNeuro, 2024
• The long-term effect of COVID-19 infection on olfaction and taste; a prospective analysis. Eur Arch Otorhinolaryngol, 2024
• Scent of COVID-19: Whole-Genome Sequencing Analysis Reveals the Role of , , and in Long-Lasting Olfactory Dysfunction. Life (Basel), 2025
• Deep learning analysis of long COVID and vaccine impact in low- and middle-income countries (LMICs): development of a risk calculator in a multicentric study. Front Public Health, 2025